(Lorcaserin-d4) N-β-D-Glucuronide Sodium Salt

• CAT Number: R035209
• CAS Number: NA
• Molecular Formula: C₁₈H₁₇D₄ClNNaO₅
• Molecular Weight: 393.83
• Purity: ≥95%
• Storage: Room temperature
• IUPAC Name: sodium;(2R,3R,4R,5S,6S)-2-[(5R)-7-chloro-2,2,4,4-tetradeuterio-5-methyl-1,5-dihydro-3-benzazepin-3-yl]-6-ethynoxyoxane-3,4,5-triol
• InChI: InChI=1S/C18H21ClNO5.Na/c1-3-24-18-16(23)14(21)15(22)17(25-18)20-7-6-11-4-5-12(19)8-13(11)10(2)9-20;/h4-5,8,10,14-18,21-23H,6-7,9H2,2H3;/q-1;+1/t10-,14+,15+,16-,17+,18-;/m0./s1/i7D2,9D2
• InChIKey: CFUYZPHRVUVVED-CWOPHXDASA-N
• SMILES: [2H]C1(CC2=C(C=C(C=C2)Cl)[C@H](C(N1[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)OC#[C-])O)O)O)([2H])[2H])C)[2H].[Na+]

(Lorcaserin-d4) N-β-D-Glucuronide Sodium Salt is a deuterated metabolite of lorcaserin, where four hydrogen atoms are replaced with deuterium. This compound is used as an internal standard in pharmacokinetic and drug metabolism studies, particularly in mass spectrometry, to accurately quantify and track lorcaserin metabolites in biological samples. The deuterium labeling ensures clear differentiation from non-labeled lorcaserin, facilitating precise analysis of the drug’s glucuronidation process. This compound is essential in pharmaceutical research for investigating the metabolic pathways, excretion, and overall pharmacodynamics of lorcaserin, a drug used for weight management.